| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 48 | 2024 | 200 | 11.410 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 15 | 2019 | 39 | 4.580 |
Why?
|
| Breast Neoplasms | 12 | 2024 | 1426 | 1.910 |
Why?
|
| Mitomycins | 6 | 2015 | 7 | 1.650 |
Why?
|
| Cell Line, Tumor | 24 | 2024 | 2128 | 1.460 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2019 | 781 | 1.440 |
Why?
|
| Chromatin | 6 | 2022 | 164 | 1.390 |
Why?
|
| Nuclear Proteins | 7 | 2019 | 287 | 1.290 |
Why?
|
| Mutation | 14 | 2024 | 1023 | 1.270 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 756 | 1.220 |
Why?
|
| DNA Replication | 6 | 2019 | 148 | 1.110 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2019 | 229 | 1.080 |
Why?
|
| Transcriptional Activation | 5 | 2015 | 164 | 1.070 |
Why?
|
| Cell Nucleus | 4 | 2020 | 351 | 0.950 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2022 | 3 | 0.910 |
Why?
|
| Signal Transduction | 9 | 2017 | 1802 | 0.860 |
Why?
|
| DNA | 10 | 2024 | 549 | 0.830 |
Why?
|
| DNA, Neoplasm | 4 | 2019 | 86 | 0.790 |
Why?
|
| Electrons | 1 | 2021 | 63 | 0.790 |
Why?
|
| DNA Adducts | 3 | 2010 | 41 | 0.770 |
Why?
|
| Neoplasms | 5 | 2015 | 1033 | 0.760 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2024 | 72 | 0.750 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2015 | 638 | 0.730 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 336 | 0.720 |
Why?
|
| DNA Damage | 12 | 2015 | 341 | 0.700 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 181 | 0.700 |
Why?
|
| Humans | 46 | 2024 | 34853 | 0.700 |
Why?
|
| Genes, p53 | 4 | 2024 | 24 | 0.690 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 23 | 0.670 |
Why?
|
| Peptides | 1 | 2020 | 308 | 0.630 |
Why?
|
| Mutant Proteins | 2 | 2015 | 48 | 0.630 |
Why?
|
| Protein Isoforms | 2 | 2018 | 121 | 0.630 |
Why?
|
| Adenosine | 2 | 2015 | 54 | 0.570 |
Why?
|
| Estrogens | 1 | 2017 | 190 | 0.550 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1149 | 0.540 |
Why?
|
| Cell Death | 5 | 2015 | 260 | 0.540 |
Why?
|
| Protein Kinases | 4 | 2015 | 91 | 0.530 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2015 | 42 | 0.530 |
Why?
|
| Female | 15 | 2024 | 19873 | 0.500 |
Why?
|
| Piperazines | 2 | 2021 | 109 | 0.490 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2014 | 40 | 0.480 |
Why?
|
| Estradiol | 2 | 2017 | 244 | 0.480 |
Why?
|
| Vesicular Transport Proteins | 1 | 2014 | 40 | 0.480 |
Why?
|
| Proteome | 1 | 2015 | 132 | 0.480 |
Why?
|
| Alternative Splicing | 1 | 2014 | 82 | 0.470 |
Why?
|
| Caenorhabditis elegans | 1 | 2014 | 74 | 0.460 |
Why?
|
| Transcription, Genetic | 8 | 2015 | 550 | 0.460 |
Why?
|
| DNA Repair | 2 | 2014 | 181 | 0.460 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 161 | 0.440 |
Why?
|
| Animals | 22 | 2024 | 14307 | 0.420 |
Why?
|
| Mitomycin | 3 | 2010 | 11 | 0.410 |
Why?
|
| Protein Binding | 9 | 2015 | 913 | 0.390 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2012 | 109 | 0.380 |
Why?
|
| Apoptosis | 7 | 2024 | 1317 | 0.380 |
Why?
|
| Sp1 Transcription Factor | 4 | 2004 | 44 | 0.370 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 968 | 0.370 |
Why?
|
| Phosphorylation | 5 | 2017 | 878 | 0.360 |
Why?
|
| Mice | 12 | 2024 | 5668 | 0.360 |
Why?
|
| HIV Long Terminal Repeat | 2 | 2000 | 19 | 0.360 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 242 | 0.350 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 605 | 0.340 |
Why?
|
| Imidazoles | 1 | 2008 | 124 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 8 | 2015 | 484 | 0.300 |
Why?
|
| Blotting, Western | 4 | 2015 | 834 | 0.290 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 391 | 0.290 |
Why?
|
| Camptothecin | 3 | 2001 | 20 | 0.270 |
Why?
|
| Up-Regulation | 4 | 2019 | 490 | 0.270 |
Why?
|
| RNA Interference | 3 | 2014 | 225 | 0.270 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 220 | 0.260 |
Why?
|
| Response Elements | 2 | 2020 | 52 | 0.250 |
Why?
|
| Cell Cycle | 3 | 2001 | 309 | 0.250 |
Why?
|
| Oligonucleotides | 3 | 2020 | 48 | 0.240 |
Why?
|
| Radiation Injuries | 1 | 2024 | 23 | 0.240 |
Why?
|
| BRCA2 Protein | 1 | 2024 | 37 | 0.240 |
Why?
|
| Mevalonic Acid | 2 | 2015 | 9 | 0.240 |
Why?
|
| BRCA1 Protein | 1 | 2024 | 47 | 0.240 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2012 | 54 | 0.240 |
Why?
|
| Down-Regulation | 2 | 2012 | 420 | 0.230 |
Why?
|
| Protein Footprinting | 1 | 2003 | 1 | 0.230 |
Why?
|
| Protein Kinase C | 1 | 2003 | 110 | 0.230 |
Why?
|
| Chromatography, Affinity | 1 | 2003 | 64 | 0.220 |
Why?
|
| Antigens, Polyomavirus Transforming | 3 | 1992 | 13 | 0.220 |
Why?
|
| Staphylococcus aureus | 3 | 1993 | 80 | 0.220 |
Why?
|
| Plasmids | 3 | 1993 | 233 | 0.220 |
Why?
|
| DNA, Viral | 5 | 2000 | 295 | 0.220 |
Why?
|
| Protein Transport | 2 | 2015 | 286 | 0.210 |
Why?
|
| Bleomycin | 1 | 2001 | 18 | 0.210 |
Why?
|
| Cell Survival | 3 | 2015 | 818 | 0.210 |
Why?
|
| Cell Line | 10 | 2004 | 1289 | 0.210 |
Why?
|
| Mice, Nude | 2 | 2020 | 323 | 0.210 |
Why?
|
| Phthalazines | 1 | 2021 | 4 | 0.210 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 71 | 0.210 |
Why?
|
| Base Sequence | 9 | 2004 | 932 | 0.190 |
Why?
|
| K562 Cells | 3 | 2006 | 31 | 0.190 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2019 | 19 | 0.180 |
Why?
|
| Gene Silencing | 2 | 2011 | 143 | 0.180 |
Why?
|
| Phenotype | 2 | 2015 | 650 | 0.180 |
Why?
|
| Blotting, Northern | 2 | 2013 | 139 | 0.180 |
Why?
|
| History, 21st Century | 1 | 2019 | 74 | 0.180 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 112 | 0.170 |
Why?
|
| History, 20th Century | 1 | 2019 | 110 | 0.170 |
Why?
|
| DNA Primers | 2 | 2014 | 269 | 0.170 |
Why?
|
| Leukemia, Myeloid | 3 | 2006 | 8 | 0.170 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 92 | 0.170 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 193 | 0.170 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 67 | 0.170 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 105 | 0.160 |
Why?
|
| E2F1 Transcription Factor | 1 | 2017 | 17 | 0.160 |
Why?
|
| Retinoblastoma Protein | 1 | 2017 | 27 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 4 | 2002 | 480 | 0.150 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2017 | 31 | 0.150 |
Why?
|
| Proteins | 1 | 2000 | 352 | 0.150 |
Why?
|
| DNA-Binding Proteins | 5 | 1993 | 522 | 0.150 |
Why?
|
| Mitosis | 1 | 2017 | 97 | 0.140 |
Why?
|
| Aged | 2 | 2018 | 6448 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 31 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 41 | 0.130 |
Why?
|
| Isotope Labeling | 1 | 2015 | 27 | 0.130 |
Why?
|
| Rad51 Recombinase | 1 | 2015 | 6 | 0.130 |
Why?
|
| Protein Stability | 1 | 2015 | 40 | 0.130 |
Why?
|
| Phosphoserine | 1 | 2015 | 18 | 0.130 |
Why?
|
| Molecular Sequence Data | 8 | 2004 | 1490 | 0.130 |
Why?
|
| Cloning, Molecular | 3 | 2008 | 310 | 0.130 |
Why?
|
| Phospholipase D | 2 | 2006 | 47 | 0.130 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 211 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1992 | 45 | 0.130 |
Why?
|
| Autophagy | 2 | 2012 | 111 | 0.130 |
Why?
|
| Cytoplasm | 1 | 2015 | 135 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 93 | 0.130 |
Why?
|
| Flow Cytometry | 2 | 2008 | 392 | 0.130 |
Why?
|
| Cell Division | 4 | 2003 | 296 | 0.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2008 | 107 | 0.120 |
Why?
|
| Germ Cells | 1 | 2014 | 70 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 116 | 0.120 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 126 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 185 | 0.120 |
Why?
|
| Middle Aged | 2 | 2018 | 9642 | 0.120 |
Why?
|
| Simian virus 40 | 3 | 1994 | 43 | 0.110 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2012 | 5 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 210 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 396 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 123 | 0.110 |
Why?
|
| Adult | 3 | 2018 | 11034 | 0.110 |
Why?
|
| Proteomics | 1 | 2015 | 302 | 0.110 |
Why?
|
| Doxycycline | 1 | 2012 | 30 | 0.110 |
Why?
|
| Binding Sites | 5 | 1998 | 597 | 0.110 |
Why?
|
| Oligopeptides | 1 | 2012 | 97 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2014 | 226 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 145 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 1993 | 520 | 0.100 |
Why?
|
| Models, Biological | 1 | 2015 | 642 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 859 | 0.100 |
Why?
|
| Recombinant Proteins | 4 | 2000 | 485 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1152 | 0.100 |
Why?
|
| Serine | 2 | 2001 | 72 | 0.100 |
Why?
|
| Gene Expression | 1 | 1993 | 639 | 0.090 |
Why?
|
| Virus Replication | 2 | 1991 | 261 | 0.090 |
Why?
|
| Cross-Linking Reagents | 2 | 2008 | 48 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2000 | 168 | 0.090 |
Why?
|
| Chromosomes, Bacterial | 1 | 1989 | 20 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2333 | 0.090 |
Why?
|
| Cyclins | 3 | 2000 | 35 | 0.090 |
Why?
|
| Deoxyribonuclease I | 2 | 2000 | 25 | 0.090 |
Why?
|
| Etoposide | 1 | 2008 | 21 | 0.080 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 129 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2004 | 1442 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 2000 | 1124 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 173 | 0.080 |
Why?
|
| Nucleosomes | 2 | 2015 | 27 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1997 | 195 | 0.070 |
Why?
|
| Genotype | 1 | 2008 | 641 | 0.070 |
Why?
|
| Homozygote | 1 | 2005 | 75 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2004 | 166 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2008 | 252 | 0.060 |
Why?
|
| Transfection | 2 | 2003 | 496 | 0.060 |
Why?
|
| Dactinomycin | 1 | 2003 | 12 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 2003 | 8 | 0.060 |
Why?
|
| Protein Kinase C-delta | 1 | 2003 | 14 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2003 | 39 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2024 | 46 | 0.060 |
Why?
|
| Luciferases | 1 | 2003 | 62 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 115 | 0.060 |
Why?
|
| Creatine Kinase | 2 | 1992 | 20 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2006 | 751 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2001 | 41 | 0.050 |
Why?
|
| Drug Stability | 1 | 2001 | 110 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 528 | 0.050 |
Why?
|
| Neomycin | 1 | 2000 | 5 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2000 | 24 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 984 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2002 | 162 | 0.050 |
Why?
|
| Baculoviridae | 2 | 1997 | 12 | 0.050 |
Why?
|
| Restriction Mapping | 2 | 1998 | 42 | 0.050 |
Why?
|
| Androstadienes | 1 | 2000 | 18 | 0.050 |
Why?
|
| Acetylation | 1 | 2000 | 94 | 0.050 |
Why?
|
| Lysine | 1 | 2000 | 104 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 577 | 0.040 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1999 | 35 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 184 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2015 | 653 | 0.040 |
Why?
|
| TATA Box | 1 | 1998 | 4 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 1998 | 9 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 1998 | 203 | 0.040 |
Why?
|
| Genes, Overlapping | 1 | 1997 | 2 | 0.040 |
Why?
|
| Spodoptera | 1 | 1997 | 11 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 52 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2015 | 350 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 430 | 0.040 |
Why?
|
| Moths | 2 | 1993 | 9 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 1995 | 18 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2015 | 40 | 0.030 |
Why?
|
| Temperature | 3 | 1994 | 275 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1994 | 8 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1995 | 117 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 52 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2006 | 122 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 1992 | 89 | 0.030 |
Why?
|
| Osmotic Pressure | 1 | 2014 | 20 | 0.030 |
Why?
|
| Elasticity | 1 | 2014 | 38 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 42 | 0.030 |
Why?
|
| Thermolysin | 1 | 1993 | 1 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 32 | 0.030 |
Why?
|
| beta-Lactamases | 1 | 1993 | 33 | 0.030 |
Why?
|
| rRNA Operon | 1 | 1992 | 1 | 0.030 |
Why?
|
| DNA Fingerprinting | 1 | 1992 | 18 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 87 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1993 | 286 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2012 | 3 | 0.030 |
Why?
|
| Prenylation | 1 | 2012 | 4 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1992 | 186 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2014 | 360 | 0.030 |
Why?
|
| Simvastatin | 1 | 2012 | 28 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 65 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1993 | 298 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1992 | 160 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 77 | 0.020 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 30 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 1989 | 184 | 0.020 |
Why?
|
| G1 Phase | 2 | 1999 | 32 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 406 | 0.020 |
Why?
|
| Nucleotides | 1 | 2004 | 33 | 0.020 |
Why?
|
| Age of Onset | 1 | 2004 | 98 | 0.020 |
Why?
|
| Half-Life | 1 | 2004 | 52 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2004 | 155 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2004 | 71 | 0.020 |
Why?
|
| Drosophila | 1 | 2004 | 133 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 3261 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 1995 | 42 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 1994 | 17 | 0.010 |
Why?
|
| Glutaral | 1 | 1993 | 5 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1993 | 22 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1993 | 46 | 0.010 |
Why?
|
| Histidine | 1 | 1993 | 36 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 86 | 0.010 |
Why?
|
| Muscles | 1 | 1992 | 64 | 0.010 |
Why?
|
| Hela Cells | 1 | 1992 | 344 | 0.010 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1990 | 9 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1992 | 376 | 0.010 |
Why?
|
| Acetaldehyde | 1 | 1990 | 10 | 0.010 |
Why?
|
| Male | 1 | 2004 | 18870 | 0.000 |
Why?
|